Trial Profile
Examination of efficacy of tolvaptan for chronic congective heart failure complicated with chronic kidney disease.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Heart failure; Renal failure
- Focus Therapeutic Use
- Acronyms TOLVAPTAN study
- 24 Jul 2014 New trial record